Alan Lotvin, MD

Executive Vice President, CVS Health and President, CVS Caremark
Alan Lotvin

Alan Lotvin, MD, is executive vice president and president, CVS Caremark, the company’s pharmacy benefits management (PBM) business. In this role, Lotvin oversees all aspects of the PBM business including sales and account management, operations, mail service pharmacy and specialty pharmacy. Lotvin also drives PBM strategy, new business development and client relationship management and retention.

Prior to his current role, Lotvin most recently served as executive vice president and chief transformation officer, CVS Health, and before that executive vice president, CVS Specialty, the specialty pharmacy of CVS Health. Before joining the company, Lotvin was president and chief executive officer of ICORE Healthcare, a Magellan Health Services company. Previously, Lotvin held multiple roles at Medco Health Solutions, including president of Medco Specialty Pharmacy Services and senior vice president of Manufacturer Contracting.

Lotvin began his career as a practicing cardiologist in New Jersey. He holds a master’s degree in Medical Informatics from Columbia University and a Medical Degree from the State University of New York Health Sciences Center in Brooklyn. Lotvin also holds US Patent #6269819 Method and Apparatus for Circulatory Valve Repair.

Icon of syringe and pills
Specialty
After a 19-year high for new drug approvals in 2015, 2016 saw a sharp decline. Including the six new biologics approved by the Center for Biologics Evaluation and Research (CBER... More
Feature
Pills and female pharmacist icon
Specialty
The impact of specialty medications on payors’ trend is not only rising, it is doing so more rapidly than ever before. From 2010 to 2015, spending on specialty drugs doubled,... More
Feature
Icon of Rx prescription script
Specialty
The U.S. Food and Drug Administration (FDA) approves drugs for specific indications, or uses. The indication identifies the condition(s) a drug is approved to treat, and it may... More
Feature
Icon of syringe and pills
Specialty
CVS Caremark analysis project that specialty drugs will account for 50 percent of all prescription spending—under both the pharmacy and medical benefit—by 2018. Spend on specialty... More
Feature
  •